Filter
511
Filtered Results: 511
Text search:
C.
Hanlen
Featured
Recommendations
80
New Publications
97
Language
Document type
No document type
226
Studies & Reports
124
Guidelines
91
Manuals
31
Training Material
15
Strategic & Response Plan
15
Fact sheets
6
Brochures
2
Infographics
1
Countries / Regions
Global
30
Ethiopia
19
Brazil
16
Latin America and the Carribbean
14
India
12
Mozambique
8
Germany
8
South Africa
8
Russia
8
Western and Central Europe
7
Indonesia
7
Rwanda
6
Asia
6
Tanzania
6
Paraguay
6
Uganda
6
Kenya
5
Philippines
5
Venezuela
5
Nepal
4
Ukraine
4
Syria
4
Malawi
4
Africa
4
Congo, Democratic Republic of
4
Angola
4
Colombia
3
Benin
3
Sierra Leone
3
China
3
Peru
3
Bangladesh
3
Zambia
3
Liberia
3
El Salvador
2
Chile
2
Zimbabwe
2
Haiti
2
Cambodia
2
Guinea-Bissau
2
Eastern Europe and Central Asia
2
Bolivia
2
Argentina
2
Lebanon
2
Eastern Europe
2
South Sudan
2
Iraq
2
Tajikistan
1
Lesotho
1
Ghana
1
Togo
1
Cameroon
1
Nigeria
1
Burkina Faso
1
Guinea
1
Dominican Republic
1
Middle East and North Africa
1
North America
1
Japan
1
East and Southern Africa
1
Yemen
1
Central African Republic
1
Chad
1
Libya
1
Ecuador
1
Myanmar / Burma
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
149
Clinical Guidelines
35
Public Health
25
Women & Child Health
24
Key Resources
11
Capacity Building
9
Pharmacy & Technologies
3
Toolboxes
Mental Health
75
COVID-19
60
Planetary Health
35
NTDs
35
TB
21
HIV
20
AMR
19
NCDs
18
Disability
15
Caregiver
14
Refugee
13
Rapid Response
12
Health Financing Toolbox
12
Global Health Education
11
Pharmacy
10
Natural Hazards
8
Conflict
7
Zika
7
Ebola
6
Social Ethics
4
Cholera
2
Health Financing
1
O objetivo desta nota conceitual e a estrutura que essa descreve tratam da eliminação de um grupo de DT e abordam os efeitos negativos para a saúde que essas DT causam (as doenças constam da Tabela 1 abaixo), e que, juntos, criam uma carga tangível sobre os indivíduos afetados, suas famílias,...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e...
This paper has been prepared to inform discussion at the conference “Beating the DRUM - Domestic Resource Use and Mobilization for accelerating progress towards SDG3,”. Many countries face critical shortfalls in domestic resource use and mobilization (DRUM) for health, threatening to push health...
Since 2002 the distribution of external funding to reproductive, maternal, newborn, and child health (RMNCH) has become more equitable and better targeted at the poorest countries and those experiencing the highest mortality. The aid envelope is not large enough or well enough concentrated to close ...
The majority of developing countries will fail to achieve their targets for Universal Health Coverage (UHC)1 and the health- and poverty-related Sustainable Development Goals (SDGs) unless they take urgent steps to strengthen their health financing. Just over a decade out from the SDG deadline of 20...
Past quantitative research on health financing has focused mostly on the level and distribution of total expenditure, with little emphasis on the specific role of public funds, despite their known importance for universal health coverage (UHC). Health Accounts data do not disaggregate public expendi...
The present information document supplements the WHO audited financial statements for 2018. It contains information on WHO's voluntary contributions by fund and by contributor in the year 2018.
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
: Development assistance for health (DAH) is one of the most important means for Japan to promote
diplomacy with developing countries and contribute to the international community. This study, for the first time,
estimated the gross disbursement of Japan’s DAH from 2012 to 2016 and clarified its...
Pregnancy and childbirth during adolescence profoundly affects the lives of millions of girls worldwide, and is a leading cause of maternal mortality and morbidity, and infant and child mortality. Every year, an estimated 21 million girls aged 15–19 years old in low- and middle-income countries be...
Between 2012 and 2016, development assistance for HIV/AIDS decreased by 20·0%; domestic financing is therefore critical to sustaining the response to HIV/AIDS. To understand whether domestic resources could fill the financing gaps created by declines in development assistance, we aimed to track spe...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t...
Introduction Community health workers (CHWs) are increasingly being tasked to prevent and manage cardiovascular disease (CVD) and its risk factors in underserved populations in low-income and middle-income countries (LMICs); however, little is known about the required training necessary for them to ...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
